Project Grant HT94252510741

Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $256K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
The federal Project Grant award of $210,292 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to develop "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma", a project focused on advancing imaging techniques to better understand metabolic changes in brain cancer. The award was granted to The Washington University, a private research institution,...
This federal Project Grant award of $155,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Washington University in University City, Missouri. The award, effective from September 30, 2025 to September 29, 2027, will investigate the "Pathophysiologic Effects of Obesogenic Diet in Neurofibromatosis Type 1 and Impact on Tumor Formation." This research aims to transform healthcare for military service members,...
This Project Grant award for $901,906 from the Defense Health Agency supports research to develop "AUTOMATIC RAPID, HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA". The funding is provided through the Military Medical Research and Development program (CFDA 12.420) which focuses on biomedical research to address military and veteran health needs. The research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
This Federal Project Grant award for $236,777.00 was provided by the Defense Health Agency to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The funding supports RAPID HIGH RESOLUTION METABOLIC IMAGING FOR IMPROVED MANAGEMENT OF PATIENTS WITH GLIOMA, a research project aimed at developing advanced imaging techniques to better manage patients with glioma, a type of brain cancer. The award term runs...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $311,000.00 in funding to The Washington University in University City, Missouri. The award supports a 2-year research project using biomedical informatics and artificial intelligence to improve detection of degenerative cervical myelopathy, a neurological disorder. As a prominent private research university, The Washington University has extensive...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,594,419.00 to The Regents of the University of California, San Francisco (UCSF) to conduct radiopathomic mapping of tumor burden for personalized management of IDH-mutant glioma. The award period runs from September 1, 2025 to August 31, 2028. As a leading academic medical center and research institution, UCSF will leverage its expertise in translational...
This federal Project Grant award for $1,493,271 was made by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2024. The award will support a 3-year research project led by The Washington University to conduct "Precision Brain Mapping and Deep Phenotyping in Pediatric Brain Tumor Patients." The key objectives of the research are to: 1) Determine the relationship between long-term cognitive outcomes and functional brain...
The Regents of the University of California, San Francisco will receive $1,983,742 through a three-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will support research integrating metabolic and physiologic magnetic resonance imaging (MRI) techniques for personalized glioblastoma radiotherapy planning from September 1, 2022 to August 31, 2025. Through this funding, researchers at the University of...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...

This federal Project Grant award of $256,208 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a research project titled "DEUTERIUM METABOLIC IMAGING TO NONINVASIVELY MEASURE METABOLIC REPROGRAMMING IN GLIOBLASTOMA" at The Washington University in University City, Missouri. The project aims to develop and apply advanced metabolic imaging techniques using deuterium to non-invasively measure metabolic changes in glioblastoma, an aggressive form of brain cancer. The award has a performance period from August 1, 2025 to July 31, 2027, and will enable the university's research team to conduct this innovative biomedical research to potentially transform healthcare for military service members and the broader public.

Generated 8/5/25, 3:22 AM